Skip to main content
. 2021 Jan 22;10(3):422. doi: 10.3390/jcm10030422

Figure 1.

Figure 1

(A) Lack of endothelin A receptor (ETAR) expression in the tubular epithelium, glomeruli, and interstitium (200×, hematoxylin). (B) Mild to moderate expression of ETAR in glomeruli with mild to moderate reactivity in the tubular epithelium. Note the focal enhanced immunoreactivity of ETAR in the kidney interstitium (200×, hematoxylin). (C) Mild to moderate immunoreactivity in a glomerulus with high ETAR expression in the tubular epithelium (200×, hematoxylin).